ATE489856T1 - Symbiotische zusammensetzung und ihr herstellungsverfahren - Google Patents
Symbiotische zusammensetzung und ihr herstellungsverfahrenInfo
- Publication number
- ATE489856T1 ATE489856T1 AT09290004T AT09290004T ATE489856T1 AT E489856 T1 ATE489856 T1 AT E489856T1 AT 09290004 T AT09290004 T AT 09290004T AT 09290004 T AT09290004 T AT 09290004T AT E489856 T1 ATE489856 T1 AT E489856T1
- Authority
- AT
- Austria
- Prior art keywords
- composition
- production process
- gen
- dehydrated
- live
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- 244000005700 microbiome Species 0.000 abstract 2
- 235000013379 molasses Nutrition 0.000 abstract 2
- 230000001195 anabolic effect Effects 0.000 abstract 1
- 230000001539 anorectic effect Effects 0.000 abstract 1
- 230000002456 anti-arthritic effect Effects 0.000 abstract 1
- 230000003178 anti-diabetic effect Effects 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 230000002402 anti-lipaemic effect Effects 0.000 abstract 1
- 230000000845 anti-microbial effect Effects 0.000 abstract 1
- 239000003472 antidiabetic agent Substances 0.000 abstract 1
- 206010061428 decreased appetite Diseases 0.000 abstract 1
- 238000001035 drying Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000000855 fungicidal effect Effects 0.000 abstract 1
- 239000000417 fungicide Substances 0.000 abstract 1
- 239000002955 immunomodulating agent Substances 0.000 abstract 1
- 229940121354 immunomodulator Drugs 0.000 abstract 1
- 230000002584 immunomodulator Effects 0.000 abstract 1
- 229960001438 immunostimulant agent Drugs 0.000 abstract 1
- 239000003022 immunostimulating agent Substances 0.000 abstract 1
- 230000003308 immunostimulating effect Effects 0.000 abstract 1
- 239000008141 laxative Substances 0.000 abstract 1
- 230000002475 laxative effect Effects 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 230000002503 metabolic effect Effects 0.000 abstract 1
- 230000000324 neuroprotective effect Effects 0.000 abstract 1
- 229940125725 tranquilizer Drugs 0.000 abstract 1
- 239000003204 tranquilizing agent Substances 0.000 abstract 1
- 230000002936 tranquilizing effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
- A23K10/33—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms from molasses
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
- Y02P60/80—Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
- Y02P60/87—Re-use of by-products of food processing for fodder production
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Physiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Botany (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09290004A EP2233015B1 (de) | 2009-01-06 | 2009-01-06 | Symbiotische Zusammensetzung und ihr Herstellungsverfahren |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE489856T1 true ATE489856T1 (de) | 2010-12-15 |
Family
ID=40524574
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT09290004T ATE489856T1 (de) | 2009-01-06 | 2009-01-06 | Symbiotische zusammensetzung und ihr herstellungsverfahren |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP2233015B1 (de) |
| CN (1) | CN102300472A (de) |
| AT (1) | ATE489856T1 (de) |
| DE (1) | DE602009000424D1 (de) |
| ES (1) | ES2357408T3 (de) |
| WO (1) | WO2010079444A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2401925B1 (de) * | 2010-06-29 | 2014-05-07 | Rosebud AG | Präbiotisches Produkt und sein Herstellungsverfahren |
| EP2677886A4 (de) * | 2011-02-23 | 2015-09-02 | Biogaia Ab | Indirekte substrate für mikroorganismen zur metabolisierung von 1,2-propandiol |
| CN102784172A (zh) * | 2012-08-16 | 2012-11-21 | 薛松晓 | 一种治疗肠易激综合征的复合益生菌及其制备方法 |
| EP3554284A4 (de) * | 2016-12-18 | 2020-08-26 | University of Florida Research Foundation, Inc. | Lactobacillus-ergänzung zur förderung der magen- und immungesundheit |
| CN109125357A (zh) * | 2018-10-24 | 2019-01-04 | 南京益恒寿生命科技有限公司 | 一种治疗肠易激综合症的益生菌-粪菌液复合液 |
| CN114698848B (zh) * | 2022-04-11 | 2024-04-09 | 深圳海创生物科技有限公司 | 一种活性多糖以及益生菌组合物及其在制备具有缓解便秘作用的保健食品或药物中的应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3147121A (en) * | 1960-12-01 | 1964-09-01 | Morrell & Co John | Preparation of silage with pediococcus cerevisiae |
| FR2773713B1 (fr) | 1998-01-16 | 2001-06-01 | Invest S Therapeutiques Essais | Composition alimentaire ou medicamenteuse a base de fer particulierement assimilable par l'organisme humain et preparations adaptees |
| FR2806417B1 (fr) | 2000-03-16 | 2003-12-26 | Lallemand Sa | Particules enrobees contenant des microorganismes vivants, procede de production et application desdites particules dans les compositions pharmaceutiques, dietetiques ou alimentaires |
| US20030185811A1 (en) * | 2001-02-06 | 2003-10-02 | Steve Teasdale | Herbal extract and preparation thereof |
| CN1871031A (zh) * | 2003-09-30 | 2006-11-29 | 基博生物技术公司 | 用于增强肾功能的组合物和方法 |
| WO2005032591A1 (en) * | 2003-09-30 | 2005-04-14 | Kibow Biotech, Inc. | Compositions and methods for augmenting kidney function |
| BG108449A (bg) | 2003-12-15 | 2005-06-30 | АЛЕКСАНДРОВ Никола | Синбиотичен продукт и приложението му като носител на природни биоактивни вещества във функционални хранителни добавки |
| WO2007081981A2 (en) * | 2006-01-11 | 2007-07-19 | Attune Foods | Probiotic food, process for its preparation and dietary regimen |
| PL1981516T3 (pl) | 2006-01-27 | 2019-03-29 | Dupont Nutrition Biosciences Aps | Zastosowanie mikroorganizmów probiotycznych w leczeniu i zapobieganiu otyłości i pokrewnym zaburzeniom |
| US20100316769A1 (en) | 2006-03-29 | 2010-12-16 | Gail Czarnecki-Maulden | Dietary supplements containing probiotics |
| EP2269465A1 (de) | 2006-05-03 | 2011-01-05 | Probiotical S.p.a. | Zusammensetzungen enthaltend Bifidobacterium adolescentis |
-
2009
- 2009-01-06 AT AT09290004T patent/ATE489856T1/de not_active IP Right Cessation
- 2009-01-06 ES ES09290004T patent/ES2357408T3/es active Active
- 2009-01-06 DE DE602009000424T patent/DE602009000424D1/de active Active
- 2009-01-06 EP EP09290004A patent/EP2233015B1/de not_active Not-in-force
-
2010
- 2010-01-06 WO PCT/IB2010/050034 patent/WO2010079444A1/fr not_active Ceased
- 2010-01-06 CN CN2010800070678A patent/CN102300472A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DE602009000424D1 (de) | 2011-01-13 |
| CN102300472A (zh) | 2011-12-28 |
| ES2357408T3 (es) | 2011-04-26 |
| EP2233015B1 (de) | 2010-12-01 |
| EP2233015A1 (de) | 2010-09-29 |
| WO2010079444A1 (fr) | 2010-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE489856T1 (de) | Symbiotische zusammensetzung und ihr herstellungsverfahren | |
| WO2010036876A3 (en) | Compositions and methods for characterizing and restoring gastrointestinal, skin, and nasal microbiota | |
| CL2011000891A1 (es) | Uso de la cepa probiotica lactobacillus reuteri dsm17938 o una composicion nutricional que comprende una cepa bacteriana probiotica lactobacillus reuteri dsm17938 porque sirve para preparar un medicamento o una composicion nutricional util para reducir las alteraciones de sueño y/o mejorar la calidad del sueño o los patrones de sueño en humanos o animales. | |
| CU20150156A7 (es) | Un método para convertir una materia prima de biomasa en un producto de un ácido amino-alfa omega- dicarboxílico | |
| CL2009000649A1 (es) | Cepa de lactobacillus rhamnosus cncm i-3690 con propiedades antimicrobianas e inmunomoduladoras; fraccion celular de la misma; y composicion que la comprende. | |
| CU20150146A7 (es) | Un método para convertir una materia prima de biomasa en un ácido alfa, beta, gamma o delta hidroxicarboxílico | |
| ES2524432T3 (es) | Bacterias del ácido láctico como cepas probióticas y composiciones que contienen las mismas | |
| ECSP10010339A (es) | Microorganismos novedosos que controlan patógenos en plantas | |
| WO2015114666A3 (en) | Treatments for resistant acne | |
| MX2014007255A (es) | Procesos y composiciones para incrementar la digestibilidad de los materiales celulosicos. | |
| UY30931A1 (es) | Amidas de 4-aril-1,4-dihidro-1,6-naftiridina sustituidas y su uso | |
| JP2012500203A5 (de) | ||
| CL2007001993A1 (es) | Compuestos derivados de pirimidilciclopentanos hidroxilados y metoxilados; procedimiento de preparacion; composicion farmaceutica; y uso del compuesto en el tratamiento de una enfermedad inflamatoria, hiperproliferante, cardiovascular, neurodegenerat | |
| CL2011000979A1 (es) | Compuestos derivados ftalazina 1,4-disustituida; composicion farmaceutica; y su uso en el tratamiento del cancer. | |
| AR060980A1 (es) | COMPOSICIoN PARA EL CONTROL DE ENFERMEDADES FOLIARES. | |
| EP2604683A4 (de) | Isopropylalkohol-produzierendes bakterium mit verbesserter produktivität durch gntr-zerstörung | |
| BR112012028918A2 (pt) | fermentação sinergística de lactobacillus rhamnosus e lactobacillus paracasei subsp paracasei | |
| ES2571998T3 (es) | Composiciones y usos médicos de derivados del ajoeno | |
| CO6470857A2 (es) | Lipopolisacárido de ochrobactrum intermedium y su uso como inmunoestimulante en mamiferos | |
| EP2570478A4 (de) | Reduktionsmittel aus zur gattung bacillus gehörenden mikroorganismen und anwendung dafür | |
| CL2008000110A1 (es) | Uso de compuestos derivados de piranona sustituidos para el tratamiento del sindrome metabolico; y compuestos derivados de piranona sustituidos. | |
| AR054730A1 (es) | Nuevas bacterias lacticas utiles como probioticos | |
| ATE542914T1 (de) | Herstellung von hochgradig isotopenmarkierten, sekundären, mikrobiellen stoffwechselprodukten sowie entsprechende stoffwechselprodukte | |
| BRPI0917395A2 (pt) | família 6 celulase com inativação diminuída por lignina | |
| JP2011096389A5 (de) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |